申请人:RESEARCH TRIANGLE INSTITUTE
公开号:US09187480B2
公开(公告)日:2015-11-17
The invention provides compounds capable of acting as antagonists at cannabanoid receptors according to the following formula: Such compounds may be used to treat conditions for which the cannabinoid receptor system has been implicated, such as obesity, liver disease, diabetes, pain, and inflammation.
该发明提供了一些化合物,其能够作为大麻素受体拮抗剂,其化学式如下:这些化合物可用于治疗大麻素受体系统被牵涉的疾病,如肥胖症、肝病、糖尿病、疼痛和炎症等疾病。